Other types of follicular lymphoma, lymph nodes of axilla and upper limb
ICD-10 C82.84 is a billable code used to indicate a diagnosis of other types of follicular lymphoma, lymph nodes of axilla and upper limb.
C82.84 refers to a specific subtype of follicular lymphoma that primarily affects the lymph nodes located in the axilla (armpit) and upper limb. Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. This subtype is often indolent, meaning it typically progresses slowly, but it can transform into a more aggressive form. Patients may present with painless lymphadenopathy, and the disease can be associated with B-symptoms such as fever, night sweats, and weight loss. Diagnosis is typically confirmed through biopsy and histological examination, which reveals follicular patterns of neoplastic cells. Staging is crucial for treatment planning and involves imaging studies such as CT scans or PET scans to assess the extent of disease involvement. Treatment options may include watchful waiting, chemotherapy, immunotherapy, or targeted therapies, depending on the stage and symptoms of the disease.
Detailed clinical notes on patient history, physical examination findings, and treatment plans.
Patients presenting with lymphadenopathy, B-symptoms, or those undergoing treatment for follicular lymphoma.
Ensure accurate staging and documentation of treatment response to avoid coding errors.
Histopathological reports detailing the type of lymphoma and any transformation.
Biopsy specimens from lymph nodes showing follicular patterns.
Clear documentation of the subtype and any associated findings is critical for accurate coding.
Used to monitor blood counts in patients undergoing treatment for lymphoma.
Document the reason for the CBC and any abnormalities noted.
Hematology specialists should ensure that CBC results are correlated with clinical findings.
Common symptoms include painless swelling of lymph nodes, fever, night sweats, weight loss, and fatigue. B-symptoms are particularly important for staging and treatment decisions.
